Genentech, Inc. - Strategy, SWOT and Corporate Finance Report - MarketLine Company Profiles

Genentech, Inc. - Strategy, SWOT and Corporate Finance Report

Genentech, Inc. - Strategy, SWOT and Corporate Finance Report - MarketLine Company Profiles
Genentech, Inc. - Strategy, SWOT and Corporate Finance Report
Published Sep 30, 2017
42 pages — Published Sep 30, 2017
Price US$ 525.00  |  Buy this Report Now

About This Report

  
Abstract:

Genentech, Inc. - Strategy, SWOT and Corporate Finance Report

Summary

Genentech, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company.

Key Highlights

Genentech, Inc. (Genentech or 'the company'), a wholly-owned subsidiary of the Roche Group, is a leading biotechnology company. The company is engaged in the discovery, development, manufacture and commercialization of medicines to treat patients with serious or life-threatening medical conditions. It is headquartered in South San Francisco, California.

Scope

- Detailed information on Genentech, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Genentech, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Genentech, Inc. including a breakdown and examination of key business segments
- Intelligence on Genentech, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Genentech, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Genentech, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Genentech, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Genentech, Inc.'s business structure, strategy and prospects.

  
Source:
Document ID
D360345E-44E3-4811-8C1B-A40BB66C6EF5
Industry
Ticker
US=US
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Company Profiles—MarketLine Company Profiles – Company information, covering everything from history and personnel to competitors, products, and services. Selected profiles of the largest global corporations also include SWOT Analysis which uncovers the strengths, weaknesses, opportunities, and threats so you can make informed assessments within minutes.

About the Author


Cite this Report

  
MLA:
MarketLine Company Profiles. "Genentech, Inc. - Strategy, SWOT and Corporate Finance Report" Sep 30, 2017. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/MarketLine-Company-Profiles/Genentech-Inc-Strategy-SWOT-and-Corporate-Finance-Report-2123-90444>
  
APA:
MarketLine Company Profiles. (2017). Genentech, Inc. - Strategy, SWOT and Corporate Finance Report Sep 30, 2017. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/MarketLine-Company-Profiles/Genentech-Inc-Strategy-SWOT-and-Corporate-Finance-Report-2123-90444>
  
US$ 525.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Company Profiles from one place.